Previous work has suggested a TIGIT receptor-positive cell density of 0.4% in RCC primary tumors and 2.1% in metastases, notably lower than receptor-positive densities for LAG3 and TIM-3; expression of these co-inhibitory receptors was also largely mutually exclusive and could define distinct tumor subtypes [6]. The gene discussed is LAG3; the disease is renal cell carcinoma.